News

Is Novo Nordisk Increasing Dosage to Defend Wegovy's Edge in Obesity?
NVO submits higher-dose Wegovy to EMA, aiming for greater weight loss and stronger defense against rivals in the obesity ...
Moleculin Biotech, Inc.: Moleculin Expands Phase 3 MIRACLE Clinical Trial into the Country of Georgia, Enrollment Update and Future Plans
Secured approval from the Regulation Agency for Medical and Pharmaceutical Activities (RAMPA) in Georgia for Phase 2B/3 MIRACLE trial Recent EU approval from the European Medicines Agency (EMA) boosts ...
Health Rounds: Experimental Bayer drug eases menopause-like symptoms from breast cancer therapy
(Reuters) -The hot flashes and night sweats that plague breast cancer survivors during years-long hormone-suppressing therapy ...
The Manila Times8h
Moleculin Expands Phase 3 MIRACLE Clinical Trial into the Country of Georgia, Enrollment Update and Future Plans
Secured approval from the Regulation Agency for Medical and Pharmaceutical Activities (RAMPA) in Georgia for Phase 2B/3 ...
The Manila Times9h
Krystal Biotech Announces First Patient Dosed in Phase 1/2 Trial of KB801 for the Treatment of Neurotrophic Keratitis
PITTSBURGH, July 09, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the "Company”) (NASDAQ: KRYS) announced today that the first patient has been dosed in its Phase 1/2 clinical trial ("EMERALD-1”), ...
EU aims to stockpile critical medical supplies for future crises
The European Union aims to stockpile critical medical equipment and vaccines in case of future health crises and to set up a network to ease coordination among EU countries, European crisis chief ...
Covington Switches to 4-Day In-Office Week, Offers August WFH
It is the latest U.S. firm to make the move, which includes the London office, easing the switch with a two-week August WFH ...
Medical Dialogues14h
Post WHO alert, Novo Nordisk seeks EMA nod for higher dose of obesity treatment Wegovy
Denmark: Following a recent World Health Organization (WHO) alert on semaglutide-containing medicines, Novo Nordisk has ...
Johnson & Johnson (JNJ) Applied to the European Medicines Agency to Expand AKEEGA Usage
Johnson & Johnson (NYSE:JNJ) is one of the 10 Best Non-Tech Stocks to Buy and Hold For 3 Years. On July 3, Janssen-Cilag, a ...